Brokers Suggest Investing in Lam Research (LRCX): Read This Before Placing a Bet
Werte in diesem Artikel
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about Lam Research (LRCX) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Lam Research currently has an average brokerage recommendation (ABR) of 1.62, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 29 brokerage firms. An ABR of 1.62 approximates between Strong Buy and Buy.Of the 29 recommendations that derive the current ABR, 19 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 65.5% and 6.9% of all recommendations.Brokerage Recommendation Trends for LRCXCheck price target & stock forecast for Lam Research here>>>The ABR suggests buying Lam Research, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.Is LRCX a Good Investment?In terms of earnings estimate revisions for Lam Research, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $3.73.Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Lam Research. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, the Buy-equivalent ABR for Lam Research may serve as a useful guide for investors.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lam Research Corporation (LRCX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Lam Research und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Lam Research
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Lam Research
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Lam Research Corp.
Analysen zu Lam Research Corp.
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2019 | Lam Research Outperform | Cowen and Company, LLC | |
22.04.2019 | Lam Research Buy | B. Riley FBR | |
24.01.2019 | Lam Research Outperform | Cowen and Company, LLC | |
21.12.2018 | Lam Research Buy | Needham & Company, LLC | |
29.10.2018 | Lam Research Neutral | B. Riley FBR |
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2019 | Lam Research Outperform | Cowen and Company, LLC | |
22.04.2019 | Lam Research Buy | B. Riley FBR | |
24.01.2019 | Lam Research Outperform | Cowen and Company, LLC | |
21.12.2018 | Lam Research Buy | Needham & Company, LLC | |
17.10.2018 | Lam Research Outperform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
29.10.2018 | Lam Research Neutral | B. Riley FBR | |
01.10.2018 | Lam Research Hold | Deutsche Bank AG | |
01.10.2018 | Lam Research Neutral | Mizuho | |
12.10.2016 | Lam Research Sector Weight | Pacific Crest Securities Inc. | |
21.04.2015 | Lam Research Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
22.10.2015 | Lam Research Underperform | RBC Capital Markets | |
05.10.2015 | Lam Research Underperform | RBC Capital Markets | |
11.11.2010 | Lam Research sell | Citigroup Corp. | |
29.07.2010 | Lam Research sell | Citigroup Corp. | |
19.03.2009 | Lam Research underperform | Credit Suisse Group |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen